SSA
MRVI icon

Schonfeld Strategic Advisors’s Maravai LifeSciences MRVI Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$415K Buy
+66,437
New +$287K ﹤0.01% 1892
2025
Q2 		– Sell
-547,207
Closed -$1.21M – 2356
2025
Q1 		$1.21M Buy
547,207
+13,564
+3% +$53.6K 0.01% 1205
2024
Q4 		$2.91M Buy
533,643
+507,743
+1,960% +$3.27M 0.02% 693
2024
Q3 		$215K Buy
+25,900
New +$224K ﹤0.01% 1790
2024
Q2 		– Sell
-15,796
Closed -$137K – 2420
2024
Q1 		$137K Sell
15,796
-40,304
-72% -$273K ﹤0.01% 1818
2023
Q4 		$367K Buy
+56,100
New +$362K ﹤0.01% 1373
2023
Q3 		– Sell
-11,800
Closed -$147K – 2102
2023
Q2 		$147K Buy
+11,800
New +$159K ﹤0.01% 1650
2023
Q1 		– Sell
-35,528
Closed -$508K – 2432
2022
Q4 		$508K Buy
+35,528
New +$559K ﹤0.01% 1519
2022
Q2 		– Sell
-61,800
Closed -$2.18M – 2828
2022
Q1 		$2.18M Sell
61,800
-7,114
-10% -$238K 0.02% 701
2021
Q4 		$2.89M Buy
68,914
+55,904
+430% +$2.26M 0.03% 603
2021
Q3 		$639K Sell
13,010
-8,221
-39% -$401K 0.01% 1152
2021
Q2 		$886K Sell
21,231
-20,469
-49% -$793K 0.01% 968
2021
Q1 		$1.49M Buy
41,700
+21,005
+101% +$696K 0.02% 756
2020
Q4 		$580K Buy
+20,695
New +$576K 0.01% 995

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Schonfeld Strategic Advisors's MRVI Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 66,437 shares worth $415K. The stake represents ﹤0.01% of the portfolio and ranks #1892 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in MRVI as recently as Q1 2025.

Schonfeld Strategic Advisors first reported a position in MRVI in Q4 2020 and has held it in 14 quarters since. The position peaked at $2.91M in Q4 2024. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Schonfeld Strategic Advisors held 66,437 shares of Maravai LifeSciences worth $415K as of Q2 2026.
  • Maravai LifeSciences was a new Schonfeld Strategic Advisors position in Q2 2026.
  • Maravai LifeSciences made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #1892 holding.
  • Schonfeld Strategic Advisors first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 14 quarters since.
  • Schonfeld Strategic Advisors's Maravai LifeSciences position peaked at $2.91M in Q4 2024.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.